Physician profile
Dustin Joseph Nowotny
NPI 1669992384
$14,037.33
in general payments reported to CMS, 2019-2025
10 companies · $9,321 in 2025
The $9,321 reported for 2025 was more than what 95% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $330 · 2021: $119 · 2022: $797 · 2023: $2,916 · 2024: $554 · 2025: $9,321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,000 · Travel and Lodging: $4,739 · Food and Beverage: $2,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,000.00 |
| Travel and Lodging | $4,738.82 |
| Food and Beverage | $2,052.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,809.73 | 2022-2025 | |
| Medical Device Business Services, INC. | $3,030.00 | 2020-2025 | Linx Reflux Management System, Matrixrib |
| Davol INC. | $2,837.02 | 2023-2025 | Phasix Mesh |
| Depuy Synthes Sales INC. | $835.21 | 2021-2024 | Matrixrib, Fibergraft Aeridyan Matrix, Vivigen Mis Delivery System |
| Distalmotion US | $300.94 | 2024 | Dexter L6 Robot |
| Conmed Corporation | $135.80 | 2024 | Airseal |
| Solventum Corporation | $35.96 | 2025 | V.A.C. Veraflo Cleanse Choice |
| Innovation Technologies INC | $20.06 | 2022 | |
| Integra Lifesciences Corporation | $17.59 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Ethicon US, LLC | $15.02 | 2025 | Linx Reflux Management System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dustin Nowotny listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.